Inventurus Knowledge Solutions Completes $557 Million TruBridge Deal

Inventurus Knowledge Solutions Limited completed the $557 million acquisition of TruBridge on July 9, 2026, bringing an electronic health record and revenue-cycle management provider serving over 700 US rural and community hospitals into IKS Health as a wholly owned subsidiary.

Why did IKS Health acquire TruBridge?

IKS Health acquired TruBridge to extend its care-enablement offering beyond its established ambulatory-care focus into the rural and community hospital segment in the United States. TruBridge provides electronic health record, or EHR, software and revenue-cycle management, or RCM, solutions for hospitals, adding capabilities that complement IKS Health's administrative and clinical workflow services.

The transaction was announced on April 23, 2026, through a definitive agreement signed by Inventurus Knowledge Solutions, Inc., the US subsidiary of IKS Health. TruBridge shareholders were offered $26.25 in cash for each common share. The transaction was originally described as being worth up to $565 million, while the completed acquisition was reported at $557 million.

Following the July 9 closing, TruBridge became a wholly owned subsidiary of IKS Health. The company said the combined organisation is positioned to support rural and community care through a broader technology and services offering. TruBridge Chief Executive Officer Chris Fowler said the partnership is intended to help healthcare organisations improve financial performance and operational stability while allowing clinicians to focus more on patient care.

What does TruBridge add to IKS Health's platform?

TruBridge adds a proprietary EHR platform and a hospital-focused RCM business to IKS Health's existing care-enablement platform. This gives IKS Health access to a segment that it identified as underserved, while broadening its addressable hospital customer base beyond physician enterprises and outpatient healthcare organisations.

TruBridge reported total income of $347 million and an operating margin of about 19% in calendar year 2025. IKS Health had said the combined entity's pro forma revenue for calendar year 2025 would be $698 million, with EBITDA of $159 million. The company has also said TruBridge serves more than 700 rural and community hospitals in the US.

IKS Health expects its AI-powered platform and TruBridge's EHR system to create a more integrated workflow across care delivery. The company has described the combination as enabling the aggregation and normalisation of longitudinal data, linking clinical context with financial outcomes. It also identified cross-selling potential across RCM and clinical documentation services within TruBridge's installed base.

How was the acquisition financed and received by investors?

IKS Health arranged initial acquisition financing of about $600 million in debt with a five-year term. The company had also issued a $603.75 million corporate guarantee to support the acquisition financing. A $77 million portion of that guarantee was later released as the transaction structure was finalised before closing.

The transaction was expected by IKS Health management to be net-profit and earnings-per-share accretive in FY27. That expectation was based on the companies' complementary operations, TruBridge's recurring EHR and RCM revenue base, and the possibility of deploying IKS Health's global delivery model across the acquired business. The company has not provided a post-closing financial performance update in the supplied disclosures.

The stock market reacted positively at both the agreement and completion stages. Shares of Inventurus Knowledge Solutions rose as much as 9.04% when the proposed deal was announced, and were reported up 3.3% at ₹1,925 on July 10 after the acquisition was completed. The shares were also reported to be up 16.3% year to date at that point.

The deal follows IKS Health's earlier acquisitions of AQuity, ThinkDTM and Arai Solutions. AQuity, acquired for $200 million in FY25, added inpatient clinical documentation, coding and medico-legal services along with more than 500 enterprise customers. IKS Health subsequently shifted that acquired operating model from a US-based human-led structure toward a technology-led and offshore-enabled model.

Conclusion

The TruBridge acquisition materially expands IKS Health's presence in US healthcare technology by adding hospital EHR software, RCM services and access to rural and community care providers. With TruBridge now wholly owned, the transaction also raises the combined entity's reported pro forma scale to $698 million of calendar-year 2025 revenue and $159 million of EBITDA.

Investors will watch for post-acquisition disclosures on integration progress, debt servicing and the company's stated FY27 net-profit and EPS accretion expectation. The key operational measure will be whether IKS Health converts its identified cross-selling opportunity into additional RCM, clinical documentation and care-enablement business across TruBridge's hospital base.